Dr. Robert Brooks explores why pharma must map its supply chains in emerging markets. In the last few years we have seen a whole raft of supply chain disruptions hit the pharmaceutical sector ...

This year’s ranking consists of a mix of high-growth metros as well as a few geographic outliers, according to Yardi Matrix data. The U.S. multifamily sector posted steady performance in 2024 ...

U.S. President Donald Trump's bruising blast of tariffs last week has thrown emerging market central banks a fresh curve ball ...